Full Press Release Details
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2022:
40th Annual J.P. Morgan Healthcare Conference
January 10 to 13, 2022
Company presentation scheduled on January 10 at 8:15 am PST
J.P. Morgan 2022 Global High Yield & Leveraged Finance Conference
February 28 to March 2, 2022
Company presentation scheduled on February 28 at 2:00 pm EST
Cowen & Co. 42nd Annual Health Care Conference
Presentation date and time will be updated on the Emergent website as the information becomes available
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Media Relations
Tags
EBS JP Morgan Healthcare
Investor Conferences